{"title":"[Ruthenium complexes as antitumor drugs: isolation of a new Ru (III) and iminodiacetic acid complex].","authors":"R Vilaplana, M G Basallote, F González-Vilchez","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.</p>","PeriodicalId":77791,"journal":{"name":"Revista espanola de oncologia","volume":"31 4","pages":"575-82"},"PeriodicalIF":0.0000,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista espanola de oncologia","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The authors discuss the convenience for using ruthenium complexes as potential antitumor drugs, and the considerable importance of these substances in regard to their biological activity. The synthesis of a new drug of the group and the results of its administration to mice bearing Ehrlich ascites cancer are reported.